Shares of Ikena Oncology, Inc. (IMA) have gained 2.4% over the past four weeks to close the last trading session at $16.6, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$132.05 indicates a potential upside of 695.5%.The mean estimate comprises three short-term price targets with a standard deviation of $125.33. While the lowest estimate of$48.02 indicates an 189.3% increase f ...